GlassScriptPhysician profile
Anamika Roy
NPI 1063517969
$1,842.71
in general payments reported to CMS, 2019-2025
21 companies · $453 in 2025
The $453 reported for 2025 was more than what 90% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.17 · 2020: $103 · 2021: $224 · 2022: $383 · 2023: $268 · 2024: $336 · 2025: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,058.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,057.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $228.17 | 2022-2025 | Entyvio, Eohilia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $228.13 | 2019-2024 | Xifaxan |
| Abbvie INC. | $206.62 | 2019-2025 | Mavyret |
| Ardelyx, INC. | $204.17 | 2022-2025 | Ibsrela |
| Lilly USA, LLC | $155.26 | 2024-2025 | Omvoh |
| Phathom Pharmaceuticals, INC. | $141.25 | 2024-2025 | Voquezna |
| Janssen Biotech, INC. | $140.62 | 2022-2025 | Stelara, Simponi Aria, Simponi |
| Redhill Biopharma INC. | $106.35 | 2020-2022 | |
| Braintree Laboratories, INC. | $91.51 | 2019-2022 | |
| Valinor Pharma, LLC | $81.86 | 2024-2025 | Movantik |
| Virtus Pharmaceuticals LLC | $43.86 | 2021 | |
| Merck Sharp & Dohme LLC | $32.57 | 2021 | |
| Intercept Pharmaceuticals, INC. | $24.97 | 2020 | |
| Sumitomo Pharma America, INC. | $24.15 | 2025 | Gemtesa |
| Madrigal Pharmaceuticals | $23.39 | 2025 | Rezdiffra |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $22.16 | 2022 | |
| Glaxosmithkline, LLC. | $22.00 | 2021 | |
| Aimmune Therapeutics, INC. | $21.02 | 2023 | |
| Exact Sciences Corporation | $19.53 | 2025 | Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $13.49 | 2023 | Quviviq |
| Nestle Healthcare Nutrition INC. | $11.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anamika Roy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.